Delivery Order SPE2DB20D7059-SPE2DB24FPZS3
Award Date
2/23/24
Potential Completion Date
2/26/24
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $27,129.90 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide ACTIVASE 100 MG VIALS. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary contract vehicle for...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $23,241.52 by the Defense Logistics Agency (DLA) to provide ACTIVASE 100 MG VIALS. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense, with a potential value...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $25,764.80 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide ACTIVASE 100 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,808,989 units of ACTIVASE 50 MG VIALS. The contract has a completion date of March 1, 2024 and a potential value of $2,864.71. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation associated with this award. This delivery order contract is part of a...
The U.S. Defense Logistics Agency Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,864.71 firm fixed price delivery order contract to provide ACTIVASE 50 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ACTIVASE 100 MG VIALS. The contract has a potential value of $17,676.17 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor to provide pharmaceuticals and medical supplies to support military treatment programs and facilities. This delivery order is...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,515,206 units of the pharmaceutical product ACTIVASE 50 MG VIALS. The contract has a completion date of February 2, 2024 and a potential value of $31,847.16. No set-aside designation was used. Amerisourcebergen Drug Corp is the prime contractor on this delivery order contract, as well...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order from the Defense Logistics Agency (DLA) with a potential value of $13,998.66 to provide Activase 100 mg vials. This delivery order is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA Troop Support Medical, valued at up to $999,999,999.00, to deliver pharmaceutical products and medical supplies in support of military treatment...
This is a $14,164.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of 100 mg vials of the pharmaceutical product ACTIVASE. This delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for the provision of a comprehensive range of medical commodities to support military treatment programs and...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The $58,802.81 firm fixed-price contract is for the supply of 4565108834 ACTIVASE 100 MG VIALS. Amerisourcebergen, a leading pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...